PUBLISHER: Value Market Research | PRODUCT CODE: 1547698
PUBLISHER: Value Market Research | PRODUCT CODE: 1547698
Global Hospital Acquired Disease Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
The global demand for Hospital Acquired Disease Testing Market is presumed to reach the market size of nearly USD XX.X Million by 2032 from USD XX.X Million in 2023 with a CAGR of 15.13% under the study period 2024-2032.
Hospital-acquired disease testing involves the diagnosis of diseases contracted from microbial infections or toxins in a healthcare facility. The intensive care unit is the most common location in a hospital where anyone can contract an illness, increasing morbidity, mortality, and hospital costs. The most common diseases tested include surgical site infections, gastroenteritis, pneumonia, meningitis, and urinary tract infections. The primary cause of these diseases is unclean hands, medical instruments such as catheters, respiratory machines, and excessive or improper use of antibiotics. The testing for these diseases involves diagnosis by sight and symptoms alone and can appear within 48 hours of admission, three days after discharge, or 30 days after an operation.
MARKET DYNAMICS
Lack of poor hygiene and the emergence of drug-resistant organisms in healthcare facilities will be the vital stimulating agents for this market's growth. Increasing the geriatric population and inflating morbidity rates among patients undergoing treatment for chronic diseases in a healthcare facility will boost this market's growth. Technological advancements in the healthcare industry and novel diagnostic techniques and tools will benefit this market's growth. Better surveillance cultures to detect unseen pathogens in colonized patients and prevent transmission of infections will be a market booster. The lack of budget, skilled labor and stringent government regulations will be a few hindrances not favorable to market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hospital Acquired Disease Testing. The growth and trends of Hospital Acquired Disease Testing industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the Hospital Acquired Disease Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Test Type
- Urinary Tract
- Surgical Site
- Pneumonia
- Bloodstream
- MRSA
- Others
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Hospital Acquired Disease Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hospital Acquired Disease Testing market include Abbott Laboratories, Alere Inc, Becton, Dickinson And Company, BioMeRieux SA F, Hoffmann-La Roche Ltd, Hologic Inc, Siemens Healthcare, Diatherix Laboratories Inc., Meridian Bioscience Inc., ThermFisher Scientific Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. HOSPITAL ACQUIRED DISEASE TESTING - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Test Type
- 3.7.2 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY TEST TYPE
- 5.1. Overview By Test Type
- 5.2. Historical and Forecast Data
- 5.3. Analysis By Test Type
- 5.4. Urinary Tract Historic and Forecast Sales By Regions
- 5.5. Surgical Site Historic and Forecast Sales By Regions
- 5.6. Pneumonia Historic and Forecast Sales By Regions
- 5.7. Bloodstream Historic and Forecast Sales By Regions
- 5.8. MRSA Historic and Forecast Sales By Regions
- 5.9. Others Historic and Forecast Sales By Regions
6. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY
- 6.1. Regional Outlook
- 6.2. Introduction
- 6.3. North America Sales Analysis
- 6.3.1 Overview, Historic and Forecast Data Sales Analysis
- 6.3.2 North America By Segment Sales Analysis
- 6.3.3 North America By Country Sales Analysis
- 6.3.4 United States Sales Analysis
- 6.3.5 Canada Sales Analysis
- 6.3.6 Mexico Sales Analysis
- 6.4. Europe Sales Analysis
- 6.4.1 Overview, Historic and Forecast Data Sales Analysis
- 6.4.2 Europe By Segment Sales Analysis
- 6.4.3 Europe By Country Sales Analysis
- 6.4.4 United Kingdom Sales Analysis
- 6.4.5 France Sales Analysis
- 6.4.6 Germany Sales Analysis
- 6.4.7 Italy Sales Analysis
- 6.4.8 Russia Sales Analysis
- 6.4.9 Rest Of Europe Sales Analysis
- 6.5. Asia Pacific Sales Analysis
- 6.5.1 Overview, Historic and Forecast Data Sales Analysis
- 6.5.2 Asia Pacific By Segment Sales Analysis
- 6.5.3 Asia Pacific By Country Sales Analysis
- 6.5.4 China Sales Analysis
- 6.5.5 India Sales Analysis
- 6.5.6 Japan Sales Analysis
- 6.5.7 South Korea Sales Analysis
- 6.5.8 Australia Sales Analysis
- 6.5.9 South East Asia Sales Analysis
- 6.5.10 Rest Of Asia Pacific Sales Analysis
- 6.6. Latin America Sales Analysis
- 6.6.1 Overview, Historic and Forecast Data Sales Analysis
- 6.6.2 Latin America By Segment Sales Analysis
- 6.6.3 Latin America By Country Sales Analysis
- 6.6.4 Brazil Sales Analysis
- 6.6.5 Argentina Sales Analysis
- 6.6.6 Peru Sales Analysis
- 6.6.7 Chile Sales Analysis
- 6.6.8 Rest of Latin America Sales Analysis
- 6.7. Middle East & Africa Sales Analysis
- 6.7.1 Overview, Historic and Forecast Data Sales Analysis
- 6.7.2 Middle East & Africa By Segment Sales Analysis
- 6.7.3 Middle East & Africa By Country Sales Analysis
- 6.7.4 Saudi Arabia Sales Analysis
- 6.7.5 UAE Sales Analysis
- 6.7.6 Israel Sales Analysis
- 6.7.7 South Africa Sales Analysis
- 6.7.8 Rest Of Middle East And Africa Sales Analysis
7. COMPETITIVE LANDSCAPE OF THE HOSPITAL ACQUIRED DISEASE TESTING COMPANIES
- 7.1. Hospital Acquired Disease Testing Market Competition
- 7.2. Partnership/Collaboration/Agreement
- 7.3. Merger And Acquisitions
- 7.4. New Product Launch
- 7.5. Other Developments
8. COMPANY PROFILES OF HOSPITAL ACQUIRED DISEASE TESTING INDUSTRY
- 8.1. Top Companies Market Share Analysis
- 8.2. Market Concentration Rate
- 8.3. Abbott Laboratories
- 8.3.1 Company Overview
- 8.3.2 Company Revenue
- 8.3.3 Products
- 8.3.4 Recent Developments
- 8.4. Alere Inc
- 8.4.1 Company Overview
- 8.4.2 Company Revenue
- 8.4.3 Products
- 8.4.4 Recent Developments
- 8.5. Becton
- 8.5.1 Company Overview
- 8.5.2 Company Revenue
- 8.5.3 Products
- 8.5.4 Recent Developments
- 8.6. Dickinson And Company
- 8.6.1 Company Overview
- 8.6.2 Company Revenue
- 8.6.3 Products
- 8.6.4 Recent Developments
- 8.7. BioMeRieux SA F
- 8.7.1 Company Overview
- 8.7.2 Company Revenue
- 8.7.3 Products
- 8.7.4 Recent Developments
- 8.8. Hoffmann-La Roche Ltd
- 8.8.1 Company Overview
- 8.8.2 Company Revenue
- 8.8.3 Products
- 8.8.4 Recent Developments
- 8.9. Hologic Inc
- 8.9.1 Company Overview
- 8.9.2 Company Revenue
- 8.9.3 Products
- 8.9.4 Recent Developments
- 8.10. Siemens Healthcare
- 8.10.1 Company Overview
- 8.10.2 Company Revenue
- 8.10.3 Products
- 8.10.4 Recent Developments
- 8.11. Diatherix Laboratories Inc.
- 8.11.1 Company Overview
- 8.11.2 Company Revenue
- 8.11.3 Products
- 8.11.4 Recent Developments
- 8.12. Meridian Bioscience Inc.
- 8.12.1 Company Overview
- 8.12.2 Company Revenue
- 8.12.3 Products
- 8.12.4 Recent Developments
- 8.13. ThermFisher Scientific Inc
- 8.13.1 Company Overview
- 8.13.2 Company Revenue
- 8.13.3 Products
- 8.13.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Test Type (USD MN)
- Urinary Tract Market Sales By Geography (USD MN)
- Surgical Site Market Sales By Geography (USD MN)
- Pneumonia Market Sales By Geography (USD MN)
- Bloodstream Market Sales By Geography (USD MN)
- MRSA Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Hospital Acquired Disease Testing Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Hospital Acquired Disease Testing Report
- Market Research Process
- Market Research Methodology
- Global Hospital Acquired Disease Testing Market Size, By Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Test Type
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Test Type (USD MN)
- Urinary Tract Market Sales By Geography (USD MN)
- Surgical Site Market Sales By Geography (USD MN)
- Pneumonia Market Sales By Geography (USD MN)
- Bloodstream Market Sales By Geography (USD MN)
- MRSA Market Sales By Geography (USD MN)
- Others Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
